A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Clinical trial NCT04184622 · COMPLETED

Trial details

NCT number: NCT04184622
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2019-12-04
Primary completion: 2022-04-01
Enrollment: 2539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.